<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">22103994</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>04</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2431</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<PubDate>
<Year>2011</Year>
<Month>Nov</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>BMC pediatrics</Title>
<ISOAbbreviation>BMC Pediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study.</ArticleTitle>
<Pagination>
<MedlinePgn>104</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2431-11-104</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">As HIV-infected infants have high mortality, the World Health Organization now recommends initiating antiretroviral therapy as early as possible in the first year of life. However, in many settings, laboratory diagnosis of HIV in infants is not readily available. We aimed to develop a clinical algorithm for HIV presumptive diagnosis in infants &lt; 10 weeks old using screening data from the Children with HIV Early Antiretroviral therapy (CHER) study in South Africa.HIV-infected and HIV-uninfected exposed infants &lt; 10 weeks of age were identified through Vertical Transmission Prevention programs. Clinical and laboratory data were systematically recorded, groups were compared using Kruskal-Wallis, analysis of variance (ANOVA), and Fisher's exact tests. Receiver Operating Characteristic (ROC) curves were compiled using combinations of clinical findings.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">417 HIV-infected and 125 HIV-exposed, uninfected infants, median age 46 days (IQR 38-55), were included. The median CD4 percentage in HIV-infected infants was 34 (IQR 28-41)%. HIV-infected infants had lower weight-for-age, more lymphadenopathy, oral thrush, and hepatomegaly than exposed uninfected infants (Adjusted Odds Ratio 0.51, 8.8, 5.6 and 23.5 respectively; p &lt; 0.001 for all). Sensitivity of individual signs was low (&lt; 20%) but specificity high (98-100%). If any one of oral thrush, hepatomegaly, splenomegaly, lymphadenopathy, diaper dermatitis, weight &lt; 50(th) centile are present, sensitivity for HIV infection amongst HIV-exposed infants was 86%. These algorithms performed similarly when used to predict severe immune suppression.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A combination of physical findings is helpful in identifying infants most likely to be HIV-infected. This may inform management algorithms and provide guidance for focused laboratory testing in some settings, and should be further validated in these settings and elsewhere.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jaspan</LastName>
<ForeName>Heather B</ForeName>
<Initials>HB</Initials>
<AffiliationInfo>
<Affiliation>Children's Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health and Centre for Infectious Diseases, Stellenbosch University, Tygerberg, South Africa. heather.jaspan@sbri.org</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Myer</LastName>
<ForeName>Landon</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Madhi</LastName>
<ForeName>Shabir A</ForeName>
<Initials>SA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Violari</LastName>
<ForeName>Avy</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gibb</LastName>
<ForeName>Diana M</ForeName>
<Initials>DM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stevens</LastName>
<ForeName>Wendy S</ForeName>
<Initials>WS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dobbels</LastName>
<ForeName>Els</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cotton</LastName>
<ForeName>Mark F</ForeName>
<Initials>MF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>MC_U122886353</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>U19 AI053217</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U19 AI53217</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>11</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Pediatr</MedlineTA>
<NlmUniqueID>100967804</NlmUniqueID>
<ISSNLinking>1471-2431</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001835">Body Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004279">DNA, Viral</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000032">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003937">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015658">HIV Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D015497">HIV-1</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010808">Physical Examination</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016133">Polymerase Chain Reaction</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013019">South Africa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014057">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000706">statistics &amp; numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2011</Year>
<Month>04</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>11</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>11</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>11</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">22103994</ArticleId>
<ArticleId IdType="pii">1471-2431-11-104</ArticleId>
<ArticleId IdType="doi">10.1186/1471-2431-11-104</ArticleId>
<ArticleId IdType="pmc">PMC3258191</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>AIDS. 2002 Nov 22;16(17):2303-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12441802</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Nov 15;362(9396):1605-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14630440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS. 2004 Jun;18 Suppl 2:S27-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15319741</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Oct 2-8;364(9441):1236-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15464184</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS. 1989 Apr;3(4):221-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2500955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J STD AIDS. 1993 Mar-Apr;4(2):83-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8476970</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trop Med Int Health. 2008 Dec;13(12):1459-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19055624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trop Med Int Health. 2005 Nov;10(11):1108-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16262735</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):504-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16652060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2007 Apr 28;369(9571):1440-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17467514</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2008 Jan 15;46(2):289-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18171265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2008 Nov 20;359(21):2233-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19020325</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 2005 Jul;83(7):559-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16175834</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>